BIOTREND Chemicals AG established
The privately held company BIOTREND Chemicals AG in Wangen / Zurich was recently established by Gunther Jaeger and Werner Hassler to provide researchers with high quality biochemicals and reagents. BIOTREND supplies approx. 1500 products under its own brand, mainly for neuroscientists in industry and academia.
BIOTREND Chemicals AG has two subsidiaries, one in Switzerland (ANAWA Trading SA (Wangen / Zurich, Switzerland, founded in 1986) and the other in Germany (BIOTREND Chemikalien GmbH in Cologne, Germany, founded in 1988). With a staff of 16 employees, the group has generated revenues totalling well over EUR 5 Mio per year.
Organizations
Other news from the department business & finance
These products might interest you

Blotting standards and reagents by Cytiva
Western blotting standards and reagents
Blotting the course to effective detection of proteins from sample preparation to analysis

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

Greener Alternative Products by Merck
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.